Average Co-Inventor Count = 3.04
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance Biopharma R&d Ip, LLC (40 from 262 patents)
2. Theravance, Inc. (22 from 386 patents)
62 patents:
1. 12351561 - Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
2. 12239638 - Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
3. 11718591 - Crystalline (2S,4R)-5-(5'-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof
4. 11718616 - JAK kinase inhibitor compounds for treatment of respiratory disease
5. 11642332 - (2R,4R)-5-(5'-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
6. 11596624 - Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
7. 11230536 - Crystalline (2S,4R)-5-(5'-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
8. 11033533 - (2R,4R)-5-(5'-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
9. 10968205 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
10. 10946006 - Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
11. 10752599 - Crystalline (2S,4R)-5-(5'-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
12. 10640467 - Process for preparing 2-(1-(tert-butoxycarbonyl)piperidine-4-yl)benzoic acid
13. 10576073 - Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
14. 10548879 - (2R,4R)-5-(5'-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
15. 10538513 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors